Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH), 13122 [2017-04620]

Download as PDF 13122 Federal Register / Vol. 82, No. 45 / Thursday, March 9, 2017 / Notices (404) 498–2741; or via email at NAnderson@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–04621 Filed 3–8–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention asabaliauskas on DSK3SPTVN1PROD with NOTICES Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: Time and Date: 8:30 a.m.–12:45 p.m., EDT, April 12, 2017. Place: 1095 Willowdale Road, Morgantown, WV 26505. The meeting is also available via webcast. Status: This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 50 people. The public is welcome to participate during the public comment period, 9:20 a.m.–9:30 a.m. EDT, April 12, 2017. Please note that the public comment period ends at the time indicated above or following the last call for comments, whichever is earlier. Members of the public who want to comment must sign up by providing their name by mail, email, or telephone, at the addresses provided below by April 7, 2017. Each commenter will be provided up to five minutes for comment. A limited number of time slots are available and will be assigned on a first come-first served basis. Written comments will also be accepted from those unable to attend the public session via an on-line form at the following Web site: http://www.cdc.gov/ niosh/bsc/contact.html. The meeting is also open to the public via webcast. If you wish to attend in person or by webcast, please see the NIOSH Web site to register (http://www.cdc.gov/niosh/ VerDate Sep<11>2014 17:43 Mar 08, 2017 Jkt 241001 bsc/) or call (404–498–2539) at least five business days in advance of the meeting. Teleconference is available toll-free; please dial (888) 397–9578, Participant Pass Code 63257516. Adobe Connect webcast will be available at https://odniosh.adobeconnect.com/ nioshbsc/ for participants wanting to connect remotely. Purpose: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors provides guidance to the Director, National Institute for Occupational Safety and Health on research and prevention programs. Specifically, the Board provides guidance on the Institute’s research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board evaluates the degree to which the activities of the National Institute for Occupational Safety and Health: (1) Conform to appropriate scientific standards, (2) address current, relevant needs, and (3) produce intended results. Matters for Discussion: NIOSH Director’s update; occupational motor vehicle safety, the nanotoxicolgy program, flu-related research, and mold investigations. Agenda items are subject to change as priorities dictate. An agenda is also posted on the NIOSH Web site (http://www.cdc.gov/ niosh/bsc/). Members of the public who wish to address the NIOSH BSC are requested to contact the Executive Secretary for scheduling purposes (see contact information below). Alternatively, written comments to the BSC may be submitted via an on-line form at the following Web site: http:// www.cdc.gov/niosh/bsc/contact.html. Contact Person for More Information: Paul J. Middendorf, Ph.D., Executive Secretary, BSC, NIOSH, CDC, 1600 Clifton Road NE., MS–E20, Atlanta, GA 30329–4018, telephone (404) 498–2500, fax (404) 498–2526. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2017–04620 Filed 3–8–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number CDC–2017–0017, NIOSH 153–D] Proposed Revised Definitions for the Levels of Evidence for NIOSH Skin Notation Profiles; Request for Comment National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Request for comments. AGENCY: The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) proposes to clarify the definitions for ‘sufficient’, ‘limited’, and ‘insufficient’ levels of evidence for the designation of NIOSH skin notations. In NIOSH Current Intelligence Bulletin (CIB) 61—A Strategy for Assigning New NIOSH Skin Notations, Appendix E.2, Evaluation of data, pp. 41–42 [http://www.cdc.gov/ niosh/docs/2009-147/pdfs/2009147.pdf] these levels of evidence are defined as the following: ‘‘Data sets classified as sufficient are those that include human and/or animal toxicity studies conducted according to standardized protocols and that provide in-depth descriptions of the exposure conditions and study findings. Data sets classified as limited via the qualitative ranking scheme contain either human and/or animal studies conducted by non-standardized protocols or contain incomplete descriptions of the exposure conditions and study findings. Data sets classified as insufficient include studies that primarily either did not apply standard protocols or did not provide an in-depth description of the exposure conditions or study findings. Data sets that receive the insufficient ranking will not be used as the basis for the NIOSH skin notation.’’ NIOSH proposes to clarify the definitions for the sufficient, limited, SUMMARY: E:\FR\FM\09MRN1.SGM 09MRN1

Agencies

[Federal Register Volume 82, Number 45 (Thursday, March 9, 2017)]
[Notices]
[Page 13122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04620]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:
    Time and Date: 8:30 a.m.-12:45 p.m., EDT, April 12, 2017.
    Place: 1095 Willowdale Road, Morgantown, WV 26505. The meeting is 
also available via webcast.
    Status: This meeting is open to the public, limited only by the 
space available. The meeting room accommodates approximately 50 people. 
The public is welcome to participate during the public comment period, 
9:20 a.m.-9:30 a.m. EDT, April 12, 2017. Please note that the public 
comment period ends at the time indicated above or following the last 
call for comments, whichever is earlier. Members of the public who want 
to comment must sign up by providing their name by mail, email, or 
telephone, at the addresses provided below by April 7, 2017. Each 
commenter will be provided up to five minutes for comment. A limited 
number of time slots are available and will be assigned on a first 
come-first served basis. Written comments will also be accepted from 
those unable to attend the public session via an on-line form at the 
following Web site: http://www.cdc.gov/niosh/bsc/contact.html. The 
meeting is also open to the public via webcast. If you wish to attend 
in person or by webcast, please see the NIOSH Web site to register 
(http://www.cdc.gov/niosh/bsc/) or call (404-498-2539) at least five 
business days in advance of the meeting. Teleconference is available 
toll-free; please dial (888) 397-9578, Participant Pass Code 63257516. 
Adobe Connect webcast will be available at https://odniosh.adobeconnect.com/nioshbsc/ for participants wanting to connect 
remotely.
    Purpose: The Secretary, the Assistant Secretary for Health, and by 
delegation the Director, Centers for Disease Control and Prevention, 
are authorized under Sections 301 and 308 of the Public Health Service 
Act to conduct directly or by grants or contracts, research, 
experiments, and demonstrations relating to occupational safety and 
health and to mine health. The Board of Scientific Counselors provides 
guidance to the Director, National Institute for Occupational Safety 
and Health on research and prevention programs. Specifically, the Board 
provides guidance on the Institute's research activities related to 
developing and evaluating hypotheses, systematically documenting 
findings and disseminating results. The Board evaluates the degree to 
which the activities of the National Institute for Occupational Safety 
and Health: (1) Conform to appropriate scientific standards, (2) 
address current, relevant needs, and (3) produce intended results.
    Matters for Discussion: NIOSH Director's update; occupational motor 
vehicle safety, the nanotoxicolgy program, flu-related research, and 
mold investigations.
    Agenda items are subject to change as priorities dictate.
    An agenda is also posted on the NIOSH Web site (http://www.cdc.gov/niosh/bsc/). Members of the public who wish to address the NIOSH BSC 
are requested to contact the Executive Secretary for scheduling 
purposes (see contact information below). Alternatively, written 
comments to the BSC may be submitted via an on-line form at the 
following Web site: http://www.cdc.gov/niosh/bsc/contact.html.
    Contact Person for More Information: Paul J. Middendorf, Ph.D., 
Executive Secretary, BSC, NIOSH, CDC, 1600 Clifton Road NE., MS-E20, 
Atlanta, GA 30329-4018, telephone (404) 498-2500, fax (404) 498-2526.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 2017-04620 Filed 3-8-17; 8:45 am]
 BILLING CODE 4163-18-P